Business Wire

Ranken Jordan Pediatric Bridge Hospital Upgrades Their Monitors to the Radical-7 Featuring Masimo SET® Pulse Oximetry

14.9.2015 12:03 | Business Wire

Del

Masimo (NASDAQ: MASI) today announced that Ranken Jordan Pediatric Bridge Hospital has upgraded their monitors to the Radical-7 featuring Masimo SET® pulse oximetry.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20150914005482/en/

Ranken Jordan Pediatric Bridge Hospital (Photo: Business Wire)

Ranken Jordan Pediatric Bridge Hospital (Photo: Business Wire)

“For children with complex medical conditions such as brain injuries, congenital defects or complications due to premature birth, our hospital specializes in bridging the gap between traditional hospital treatments and going home,” said Laureen K. Tanner, RN, MSN, FACHE, President and Chief Executive Officer of Ranken Jordan Pediatric Bridge Hospital. “Breakthrough medical technology like this helps our team make the impossible possible on a daily basis.”

The Radical-7 features Masimo SET® Measure-through-Motion and Low Perfusion™ pulse oximetry, shown in multiple studies to significantly reduce false alarms and accurately monitor for true alarms.1,2 The benefits of Masimo SET® have been proven in more than 100 independent and objective studies and used on more than 100 million patients in leading hospitals.3,4 Researchers have found that Masimo SET®, in combination with changes in clinical practice, led to a reduction in severe retinopathy of prematurity (ROP) in pre-term infants.5 In a study of newborns, researchers have found critical congenital heart disease (CCHD) was detected 63% of the time by standard screening and 83% of the time when screening with Masimo SET® was added.6 The Radical-7 allows hospitals the ability to upgrade their monitor with other breakthrough measurements that are only available with Masimo rainbow® technology.

“The amazing team at Ranken Jordan Pediatric Bridge Hospital has been taking care of children with complex needs for over 70 years. They are the only pediatric sub acute facility in Missouri and one of the largest in the Midwest,” stated Joe Kiani, Founder and CEO of Masimo. “Performance in challenging situations is key and we are happy that their clinical team now has access to our flagship monitor. It is our privilege to help facilities like Ranken Jordan help kids and families safely transition from the acute care hospital to home.”

About Ranken Jordan Pediatric Bridge Hospital

Ranken Jordan offers care through a 62,000 square-foot, 34-bed inpatient program and several outpatient programs, including outpatient therapy, intensive day treatment, a physiatry clinic and a comprehensive orthopedic rehabilitation clinic. The current hospital building houses ultramodern equipment and is specifically designed to entice patients to get out of their rooms and engage in daily life-centered activities. Ranken Jordan's Community Program provides free recreational and educational programs for all kids and their families. For more information, contact us or call 314-872-6400. www.rankenjordan.org

About Masimo

Masimo (NASDAQ: MASI) is the global leader in innovative noninvasive monitoring technologies that significantly improve patient care - helping solve "unsolvable" problems. In 1995, the company debuted Measure-Through Motion and Low Perfusion pulse oximetry, known as Masimo SET®, which virtually eliminated false alarms and increased pulse oximetry's ability to detect life-threatening events. More than 100 independent and objective studies have shown that Masimo SET® outperforms other pulse oximetry technologies, even under the most challenging clinical conditions, including patient motion and low peripheral perfusion. In 2005, Masimo introduced rainbow Pulse CO-Oximetry technology, allowing noninvasive and continuous monitoring of blood constituents that previously could only be measured invasively, including total hemoglobin (SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), and Pleth Variability Index (PVI®), in addition to SpO2, pulse rate, and perfusion index (PI). In the U.S., Masimo rainbow® SET pulse CO-Oximeter instruments and sensors are indicated to provide noninvasive monitoring of arterial oxygen saturation (SpO2) and pulse rate (PR), carboxyhemoglobin saturation (SpCO®), methemoglobin saturation (SpMet®), total hemoglobin concentration (g/dl SpHb), and/or respiration rate (RRa®). The devices are not intended to replace laboratory measurements of hemoglobin and have not been cleared by FDA to detect bleeding or reduce the amount or frequency of red blood cell (RBC) transfusions. Additional information about Masimo and its products may be found at www.masimo.com. @MasimoInnovates

Forward-Looking Statements

This press release includes forward-looking statements as defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, in connection with the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current expectations about future events affecting us and are subject to risks and uncertainties, all of which are difficult to predict and many of which are beyond our control and could cause our actual results to differ materially and adversely from those expressed in our forward-looking statements as a result of various risk factors, including, but not limited to: risks related to our assumptions regarding the repeatability of clinical results; risks related to our belief that Masimo's unique noninvasive measurement technologies, including: total hemoglobin (SpHb®) contribute to positive clinical outcomes and patient safety; risks related to our belief that Masimo noninvasive medical breakthroughs provide cost-effective solutions with comparable accuracy and unique advantages, including: immediate and continuous results that enable earlier treatment without causing invasive trauma in all patients and in every clinical situation; as well as other factors discussed in the "Risk Factors" section of our most recent reports filed with the Securities and Exchange Commission ("SEC"), which may be obtained for free at the SEC's website at www.sec.gov. Although we believe that the expectations reflected in our forward-looking statements are reasonable, we do not know whether our expectations will prove correct. All forward-looking statements included in this press release are expressly qualified in their entirety by the foregoing cautionary statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. We do not undertake any obligation to update, amend or clarify these statements or the "Risk Factors" contained in our most recent reports filed with the SEC, whether as a result of new information, future events or otherwise, except as may be required under the applicable securities laws.

Masimo, SET, Signal Extraction Technology, Improving Patient Outcome and Reducing Cost of Care by Taking Noninvasive Monitoring to New Sites and Applications, rainbow, SpHb, SpOC, SpCO, SpMet, PVI are trademarks or registered trademarks of Masimo.

1 Barker SJ. Anesth Analg. 2002 Oct;95(4):967-72
2 Shah N et al. J. Clin Anesth. 2012 Aug; 24(5):385-91.
3 All studies available at http://www.masimo.com/cpub/clinical-evidence.htm
4 Data on file
5 Castillo A et al. Acta Paediatr. 2011 Feb;100(2):188-92
6 de-Wahl Granelli AD et al. BMJ. 2009;338

Contact information

Ranken Jordan Pediatric Bridge Hospital
Tyler Mathews
Marketing/Communications
314-872-6503
Tyler.mathews@rankenjordan.org
or
Masimo
Irene Paigah
858-859-7001
irenep@masimo.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

IBC’s Big Screen to Explore the Future of Camera and Display Technologies and the Business Behind Cinema22.8.2017 16:58Pressemelding

IBC today announced the details of its Big Screen programme, taking place in a specially built auditorium designed to IBC’s specifications and featuring the very latest in cinema technology. With the latest Dolby Vision dramatic imaging and Dolby Atmos immersive audio sound installation, the four-day programme examines and demonstrates the hottest topics, themes, and insights surrounding the art, science, and business of cinema - from capture through to exhibition. As well as being the home of the Big Screen programme, the auditorium will screen in Dolby Vision and Dolby Atmos, Baby Driver, the acclaimed Edgar Wright feature from 2017. The programme for 2017, which has been shaped by a committee of global industry professionals, is an insightful examination of the future of cinema. From virtual reality in cinema to laser and camera assessments, visitors will get up to speed

Digi Communications N.V. Announces the Publishing of an Update to the Investigation by the Romanian National Anti-Corruption Directorate22.8.2017 16:38Pressemelding

In connection with the investigation triggered by the Romanian National Anti-Corruption Directorate (“DNA”), which we have previously disclosed to the market and to our investors in the initial public offering prospectus dated 26 April 2017, in the supplemental prospectus dated 8 May 2017 (together, the “Prospectus”), as well as in the subsequent public reports, we inform you that, based on the public release no 832/VIII/3 issued on 22 August 2017, the DNA sent to court under the judiciary control Mr. Ioan Bendei (Vice-president of the Board of Directors of RCS & RDS S.A. – the Company’s subsidiary („RCS&RDS”)) in connection with the offences of bribery and accessory to money laundering, as well as RCS&RDS in connection with the offences of bribery and money laundering, INTEGRASOFT S.R.L. (one of RCS&RDS’s subsidiaries in Romania) in connection with the offence of accessory to mon

SailPoint Named a Leader in Cloud-based Identity Governance22.8.2017 14:00Pressemelding

SailPoint, the leader in enterprise identity management, was recently named the overall market leader in KuppingerCole’s 2017 “Leadership Compass: Identity as a Service: Cloud-based Provisioning, Access Governance and Federation.” In addition to being named a leader in every category of the report, SailPoint received superior rankings in four of the five evaluation criteria: security, functionality, interoperability and usability. KuppingerCole is an international and independent analyst organization with a strong focus on Information Security and Identity and Access Management. KuppingerCole’s Leadership Compass reports provide an in-depth analysis of the main players in the market, defining each as a follower, challenger or leader. The Leadership Compass Report for IDaaS evaluates leaders in innovation, product features, and market reach for identity-as-a-service offerings tar

Meggitt Training Systems to Exhibit at DSEI 201722.8.2017 14:00Pressemelding

Meggitt Training Systems, the leading provider of integrated live-fire and virtual weapons training products and services for armed forces and law enforcement, will participate at Defence and Security Equipment International (DSEI) through the Georgia Department of Economic Development. The military and security industry event will be held September 12-15, 2017 at ExCeL in London, England. “Today’s threats necessitate maximum realism, despite stretched budgets, and that’s what Meggitt provides to government and commercial customers globally,” said Mark Mears, managing director at Meggitt Training Systems, Ltd. “Although proudly based in Georgia, Meggitt Training Systems is part of Meggitt PLC, a UK-headquartered corporation. As such, we particularly look forward to engaging with current and prospective customers at DSEI, the UK’s largest defense and security trade show.” On

Camelbay Real Estate Management NL B.V. Selects Yardi Voyager22.8.2017 13:58Pressemelding

Camelbay Real Estate Management NL B.V. will utilise Yardi Voyager® 7S, a browser-agnostic, fully mobile Software-as-a-Service platform, as its accounting and property management platform. Camelbay will use Yardi Voyager to streamline its property management, leasing and accounting processes for its Dutch real estate portfolio, which is predominantly comprised of commercial office assets. “The automation, transparency and fully integrated accounting and property management that Voyager provides will help us manage our daily financial and operational activities more efficiently and enhance our competitive position within the Dutch office market,” said Alon Levy, Director of Camelbay Real Estate Management NL B.V. “We are very pleased to welcome Camelbay as our latest client in the Netherlands,” said Neal Gemassmer, Vice President of International for Yardi.

Laser Design CyberGage®360, Automated 3D Scanning & Inspection System Adopted by Proto Labs in their State-of-the-Art Metrology Lab22.8.2017 13:44Pressemelding

Laser Design, Inc., a subsidiary of CyberOptics (NASDAQ:CYBE), and premier provider of ultra-precise 3D scanning systems and services, announces the adoption of the CyberGage360 3D Scanning and Inspection system by Proto Labs, the world’s fastest digital manufacturing source for custom prototypes and low-volume production parts providing unprecedented speed-to-market value for designers and engineers. “At Proto Labs, we strive to challenge the traditional rules of manufacturing in order to deliver custom manufactured components at unprecedented speeds,” said Dylan Lundberg, Senior Manufacturing Engineer of Protoworks, Proto Labs’ R&D lab. “Everything we do revolves around reducing our customers’ time to market and we do that by digitalizing the entire manufacturing process. From our front-end services to our proprietary processes on the manufacturing floor, you will find thr

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom